Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Curtiss-Wright (CW) initiated with a Market Perform at William Blair. 2. Alnylam (ALNY) initiated with an Overweight at Morgan Stanley. 3. Ionis Pharmaceuticals (IONS) initiated with an Equal Weight at Morgan Stanley. 4. Trillium Therapeutics (TRIL) initiated with a Buy at Ladenburg. 5. Zebra Technologies (ZBRA) initiated with a Buy at CLSA. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

Stifel raised the firm's price target on Curtiss-Wright to $272 from $255 and keeps a Buy rating on the shares. In a Q1 preview for the diversified industrials group, the firm says it is "generally fairly neutral on stocks under our coverage" with an expectation that companies will be seeing improving demand fundamentals with improving short cycle and waning inventory destocking, offset by the strong performance of the stocks during the quarter. In general, the firm is expecting management commentary to be more positive on the second half, while maintaining a relatively cautious approach to guidance, the analyst tells investors in the preview.